FATE
Fate Therapeutics Inc

6,249
Loading...
Loading...
Latest Earnings Results: Q2 '25
Reported: Aug 12

Estimated EPS

-$0.35

Reported EPS

-$0.29

Surprise

+17.34%

Estimated Rev

$0.86M

Reported Rev

$1.91M

Surprise

+120.65%

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.30
--
--
N/A
Q2 '25
-$0.35
-$0.29
17.34%
BEAT
Q1 '25
-$0.38
-$0.32
16.52%
BEAT
Q4 '24
-$0.43
-$0.44
-1.64%
MISSED
Q3 '24
-$0.42
-$0.40
3.95%
BEAT

Latest FATE News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.